Initially, based on TargetScan (TargetScan Human 7.0) analysis and published literature, we found that EZH2 is a direct target of let-7c in cancer cells7,19 and has a highly conserved let-7c binding site in its 3′-UTR (Supplementary Figure 2A). Here, EZH2 is linked to cancer.